Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Collrane Frivold

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Infectious Diseases|October 21, 2024
Maternal ImmunizationHye-Kyung Cho, Collrane Frivold, Helen Y Chu
Drug Delivery and Translational Research|October 16, 2021
Manufacturing readiness assessment for evaluation of the microneedle array patch industry: an exploration of barriers to full-scale manufacturingBen Creelman, Collrane Frivold, Sierra Jessup, et al.
Vaccine|July 3, 2019
Potential use of microarray patches for vaccine delivery in low- and middle- income countriesNicolas Peyraud, Darin Zehrung, Courtney Jarrahian, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 14, 2022
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic ModellingHannah Kinvig, Nicolas Cottura, Andrew Lloyd, et al.
European Journal of Drug Metabolism and Pharmacokinetics|September 30, 2022
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic ModellingHannah Kinvig, Nicolas Cottura, Andrew Lloyd, et al.
Vaccine: X|August 7, 2019
Evaluating the cost per child vaccinated with full versus fractional-dose inactivated poliovirus vaccineMercy Mvundura, Jui-Shan Hsu, Collrane Frivold, et al.
Influenza and Other Respiratory Viruses|December 11, 2023
Acute respiratory infections among individuals seeking outpatient care in the states of Washington and Michigan by pregnancy status, 2011-2016Collrane Frivold, Denise J McCulloch, Seda Ekici, et al.
PLOS Global Public Health|March 24, 2023
Evaluating the potential cost-effectiveness of microarray patches to expand access to hepatitis B birth dose vaccination in low-and middle-income countries: A modelling studyChristopher P Seaman, Mercy Mvundura, Collrane Frivold, et al.
American Journal of Epidemiology|August 21, 2025
Racial Affinity Caucuses (RACs) as Anti-Racist Pedagogy in an Epidemiology CourseWendy E Barrington, Ramya Kumar, Collrane Frivold, et al.
Vaccine|March 25, 2025
Identification of potential vaccines for use with microarray patches in low- and middle-income countries: An assessment from the Vaccine Innovation Prioritisation Strategy AllianceCollrane Frivold, Birgitte Giersing, Jean-Pierre Amorij, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Infectious Diseases|October 21, 2024
Maternal ImmunizationHye-Kyung Cho, Collrane Frivold, Helen Y Chu
Drug Delivery and Translational Research|October 16, 2021
Manufacturing readiness assessment for evaluation of the microneedle array patch industry: an exploration of barriers to full-scale manufacturingBen Creelman, Collrane Frivold, Sierra Jessup, et al.
Vaccine|July 3, 2019
Potential use of microarray patches for vaccine delivery in low- and middle- income countriesNicolas Peyraud, Darin Zehrung, Courtney Jarrahian, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 14, 2022
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic ModellingHannah Kinvig, Nicolas Cottura, Andrew Lloyd, et al.
European Journal of Drug Metabolism and Pharmacokinetics|September 30, 2022
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic ModellingHannah Kinvig, Nicolas Cottura, Andrew Lloyd, et al.
Vaccine: X|August 7, 2019
Evaluating the cost per child vaccinated with full versus fractional-dose inactivated poliovirus vaccineMercy Mvundura, Jui-Shan Hsu, Collrane Frivold, et al.
Influenza and Other Respiratory Viruses|December 11, 2023
Acute respiratory infections among individuals seeking outpatient care in the states of Washington and Michigan by pregnancy status, 2011-2016Collrane Frivold, Denise J McCulloch, Seda Ekici, et al.
PLOS Global Public Health|March 24, 2023
Evaluating the potential cost-effectiveness of microarray patches to expand access to hepatitis B birth dose vaccination in low-and middle-income countries: A modelling studyChristopher P Seaman, Mercy Mvundura, Collrane Frivold, et al.
American Journal of Epidemiology|August 21, 2025
Racial Affinity Caucuses (RACs) as Anti-Racist Pedagogy in an Epidemiology CourseWendy E Barrington, Ramya Kumar, Collrane Frivold, et al.
Vaccine|March 25, 2025
Identification of potential vaccines for use with microarray patches in low- and middle-income countries: An assessment from the Vaccine Innovation Prioritisation Strategy AllianceCollrane Frivold, Birgitte Giersing, Jean-Pierre Amorij, et al.
Pageof 3